版本:
中国

BRIEF-Eiger announces results of ubenimex and leukotriene b4 (LTB4) modulation in experimental lymphedema

May 17 Eiger Biopharmaceuticals Inc

* Eiger announces results demonstrating benefit of ubenimex and leukotriene B4 (LTB4) modulation in experimental lymphedema Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐